Research and Innovation Grant

Annually the Scientific Affairs and Clinical Practice (SACP) Committee are responsible for awarding ACB Research and Innovation Grants (formerly ACB Scientific Scholarships).

The grants are open to all Ordinary members of the ACB. Applications open in June and will be considered during the September SACP Committee meeting. Funding is secured annually and information on funding limits can be seen in the guidelines below.

The SACP encourage applications that promote the ACB '5 year plan' themes of:  Innovation, Environment and Inclusion.

Please see the guidelines for more details or contact us via the Deputy Director.

 

Guidelines

1. Document Control

This is the inaugural year of the ACB Research and Innovation Grant (formerly ACB Scientific Scholarships)

Document created: 18th June 2021
Next revision due: May 2022 (in preparation of the 2022 round)

2. Purpose of grants

  1. The purpose of the grants is to support high-quality, original, ethical research and innovation in Clinical Biochemistry, Microbiology or Immunology.
  2. Any member-in-good-standing of the Association may apply.
  3. Grants will most likely be awarded to projects with the greatest potential for positive impact on patient outcomes.
  4. The committee also wishes to recognise and support projects where there is a high likelihood that there will be high-quality publication or publications to underpin the generalisability of results and make the benefits of the research available to a wider population of patients.
  5. The Committee will also look favourably on research that encourages collaboration between the public and the private sector. Collaboration between the aforementioned disciplines is particularly encouraged.

3. Eligibility

  1. Eligibility is restricted to Ordinary members of the Association for Clinical Biochemistry and Laboratory Medicine.
  2. Non-members of the Association may not apply.
  3. Applications from members with unpaid membership fees at the time of application for consideration by the Scientific Affairs and Clinical Practice Committee will be rejected without further consideration.

4. Amount of support available

  1. Funds of up to £30,000 are currently available and with a top limit of £9,000 that can be requested per application. It is anticipated that 3 to 5 projects will receive a grant. The final number of projects supported is dependent on the amount of support requested and is the responsibility of the Scientific Affairs and Clinical Practice Committee.
  2. Grants must be claimed within 12 calendar months of the date on the letter from the ACB team confirming the award offer.
  3. The decision of the Scientific Affairs and Clinical Practice Committee is final. No correspondence will be entered into.

5. Approved uses for financial support

  1. Support may be used for necessary equipment, reagents, calibrators, controls and consumables.
  2. Support is not available for salaries or staffing or labour costs.
  3. Support is not available for travel, accommodation or subsistence costs- however a separate application to the CP Stewart award would be considered for this purpose if required to aid the project.

6. Criteria against which applications will be judged

Surviving applications will be judged primarily according to the following criteria:

  1. Does the study address an important clinical problem relating to clinical biochemistry, immunology or microbiology (Weighting 20%)
  2. Are the aims clear? (Weighting 5%)
  3. Are the aims realistic? (Weighting 5%)
  4. Is the methodology capable of answering the questions posed? (Total Weighting 50% as outlined below) This is the most important section and must clearly state how the project will answer the questions posed. You may wish to consider where appropriate:
    1. Statistical Methods (Weighting 14%)
    2. Clinical Material (Weighting 13%)
    3. Technical/Study Design (Weighting 18%) 
    4. Does the group have significant experience and expertise in the proposed area of research? (Weighting 5%)
  5. Are there other compelling reasons why the study should / should not be supported? For example, the study may already have ethical approval (Weighting 5%)
  6. Have the applicants clearly stated the likely impact of their study on patient outcomes and/or patient experience (Weighting 15%)

7. Timelines

  1. Applications open on 24th June 2021, close at noon on 6th August 2021 (extended deadline, previously 31st July 2021) and will be sent for consideration independently by all members of the Scientific Affairs and Clinical Practice Committee in August/September.
  2. The aim is to inform applicants of the funding outcome by 30th September 2021.

8. Acknowledgement

  1. Successful applicants are required to acknowledge ACB funding in any spoken or written presentation, and may be invited to present data at ACB National meetings.
  2. Applicant should inform the Scientific Affairs and Clinical Practice Committee on progress of the work, with a formal update at 6 months and at completion.
  3. Applicants should be prepared to work with the ACB on the promotion and publication of findings.

 

 

Apply for ACB Research and Innovation Grant

Applications open on Thursday 24th June and close at noon on 6th August 2021 (extended deadline, previously 31st July 2021)

This year applications will be assessed by the Committee blinded to the applicant's personal and work details.
The application process is therefore split into two sections; details to be submitted using the below online form and the details of the project to be submitted using the Research Details Form and uploaded in the relevant section below.
 

 

The Research Details form template to complete and upload with your application is available to download below

Research and Innovation Grant Details Form

 

If you experience any technical issues submitting this online form please send an email to ACB Membership Manager Mike Lester ([email protected]) who can check your application has been received as intended.